ResearcherUniversity of CopenhagenNo recent work listed
Carl A.K. Borrebaeck
Matched on ORCID iD 0000-0003-2461-2354; OpenAlex author ID A5086974017. Sources: OpenAlex.
Their work
- Papers
- 6 (first author 0, last author 4)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 30
2012: 1 paper · 2013: 1 paper · 2014: none · 2015: 1 paper · 2016: 1 paper · 2017: none · 2018: 2 papers
Papers 6
- The Interface of Pancreatic Cancer With Diabetes, Obesity, and Inflammation: Research Gaps and Opportunities: Summary of a National Institute of Diabetes and D… Co-author DOI 10.1097/mpa.0000000000001037↗
- Serum Biomarker Signature-Based Liquid Biopsy for Diagnosis of Early-Stage Pancreatic Cancer. Last author DOI 10.1200/jco.2017.77.6658↗
- Plasma protein profiling in a stage defined pancreatic cancer cohort - Implications for early diagnosis. Co-author DOI 10.1016/j.molonc.2016.07.001↗
- A Multicenter Trial Defining a Serum Protein Signature Associated with Pancreatic Ductal Adenocarcinoma. Last author DOI 10.1155/2015/587250↗
- Modelling the benefits of early diagnosis of pancreatic cancer using a biomarker signature. Last author DOI 10.1002/ijc.28256↗
- Identification of serum biomarker signatures associated with pancreatic cancer. Last author DOI 10.1158/0008-5472.can-11-2883↗
Closest collaborators
The 25 strongest of 30 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Christer Wingren · 4 shared papers, 2012–2018 · strength 0.22
- Paper Serum Biomarker Signature-Based Liquid Biopsy for Diagnosis of Early-Stage Pancreatic Cancer. DOI 10.1200/jco.2017.77.6658↗
- Paper Plasma protein profiling in a stage defined pancreatic cancer cohort - Implications for early diagnosis. DOI 10.1016/j.molonc.2016.07.001↗
- Paper A Multicenter Trial Defining a Serum Protein Signature Associated with Pancreatic Ductal Adenocarcinoma. DOI 10.1155/2015/587250↗
- Anna Sandström Gerdtsson · 3 shared papers, 2012–2016 · strength 0.14
- Paper Plasma protein profiling in a stage defined pancreatic cancer cohort - Implications for early diagnosis. DOI 10.1016/j.molonc.2016.07.001↗
- Paper A Multicenter Trial Defining a Serum Protein Signature Associated with Pancreatic Ductal Adenocarcinoma. DOI 10.1155/2015/587250↗
- Paper Identification of serum biomarker signatures associated with pancreatic cancer. DOI 10.1158/0008-5472.can-11-2883↗
- Brett C. Sheppard · 1 shared paper, 2018 · strength 0.08
- Linda Dexlin Mellby · 1 shared paper, 2018 · strength 0.08
- Børge Grønne Nordestgaard · 1 shared paper, 2018 · strength 0.08
- Rosalie C. Sears · 1 shared paper, 2018 · strength 0.08
- Julia Sidenius Johansen · 1 shared paper, 2018 · strength 0.08
- Roland E. Andersson · 2 shared papers, 2012–2013 · strength 0.07
- William E. Fisher · 1 shared paper, 2018 · strength 0.06
- James L. Abbruzzese · 1 shared paper, 2018 · strength 0.06
- Edgar G. Engleman · 1 shared paper, 2018 · strength 0.06
- Aida Habtezion · 1 shared paper, 2018 · strength 0.06
- Alvin C. Powers · 1 shared paper, 2018 · strength 0.06
- Murray Korc · 1 shared paper, 2018 · strength 0.06
- Dana K. Andersen · 1 shared paper, 2018 · strength 0.06
- Zobeida Cruz‐Monserrate · 1 shared paper, 2018 · strength 0.06
- Stephen Jacob Pandol · 1 shared paper, 2018 · strength 0.06
- Anil K. Rustgi · 1 shared paper, 2018 · strength 0.06
- Guido Eibl · 1 shared paper, 2018 · strength 0.06
- Suresh T. Chari · 1 shared paper, 2018 · strength 0.06
- Craig D. Logsdon · 1 shared paper, 2018 · strength 0.06
- Costas Andreas Lyssiotis · 1 shared paper, 2018 · strength 0.06
- Eithne Costello · 1 shared paper, 2018 · strength 0.06
- Jihui Hao · 1 shared paper, 2016 · strength 0.06
- He Ren · 1 shared paper, 2016 · strength 0.06
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.